|
|
|
Volumn 97, Issue 3, 2001, Pages 15-
|
|
Licensed to kill superbugs. Will a new class of antibiotic cut the incidence of hospital-acquired infections?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETAMIDE DERIVATIVE;
ANTIINFECTIVE AGENT;
LINEZOLID;
OXAZOLIDINONE DERIVATIVE;
ARTICLE;
CROSS INFECTION;
DRUG APPROVAL;
HUMAN;
LEGAL ASPECT;
SUPERINFECTION;
UNITED KINGDOM;
ACETAMIDES;
ANTI-INFECTIVE AGENTS;
CROSS INFECTION;
DRUG APPROVAL;
GREAT BRITAIN;
HUMANS;
OXAZOLIDINONES;
SUPERINFECTION;
|
|
EID: 0035905992
PISSN: 09547762
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
